MAXIPHARMA
Business purpose.
Exploiter une centrale d'achat pharmaceutique conformément aux dispositions du 15ème alinéa de l'article R. 5124-2 du Code de Santé Publique, Développer et animer un groupement de pharmacies d'officine. Favoriser les achats des adhérents par leur massification.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Agents specialised in the sale of other particular products (46.18Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- 20 to 49 employees
- Created
- 23 Oct 2018
- Share capital
- 70,000.00 EUR
- Registered with the trade register
- 12 Nov 2018
- Financial year end
- 28/02
- Establishments
- 2
Directors
- Information not disclosable President de SAS
Court decisions
Decisions published by the French Court of Cassation (Judilibre) that cite this company by its SIREN number. Individuals are pseudonymised.
- Ruling, Cour d'appel de Bordeaux Confirme la décision déférée dans toutes ses dispositions, à l'égard de toutes les parties au recours 25 Mar 2026 · no. 25/03645
Other companies at the same address
17 other company head offices are registered at this address.
Establishments
-
84374950800019 31810 VERNET
Financial strength
Financial score
46 / 100 D
Confidence: low · computed on the financial year ended 28 Feb 2025
- Equity to assets (30.9 %)
- 12.5 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (186.0 %)
- 8.2 out of 20
- Debt (55.5 %)
- 9.3 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
96 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (8.0 years)
- 16.1 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 28 Feb 2025 | 0 € | — | 0 € | 113,132 € |
| 29 Feb 2024 | 0 € | -100.0 % | 0 € | 190,361 € |
| 31 Dec 2022 | 5,558,258 € | — | 356,033 € | 152,685 € |
| 31 Dec 2021 | 0 € | — | 0 € | 344,644 € |
| 31 Dec 2020 | 0 € | — | 0 € | 166,846 € |
| 31 Dec 2019 | 0 € | first year on record | 0 € | 41,878 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Amendment 5 Dec 2025
- Court :
- Greffe du Tribunal de Commerce de Toulouse
- Amendment :
- modification survenue sur l'administration
BODACC B n 20250234, annonce n 989 · Proof of publication (PDF)
-
Filing of accounts 1 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de toulouse
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 28/02/2025
BODACC C n 20250146, annonce n 2166 · Proof of publication (PDF)
-
Amendment 20 Jun 2025
- Court :
- Greffe du Tribunal de Commerce de Toulouse
- Amendment :
- modification survenue sur l'administration
BODACC B n 20250117, annonce n 551 · Proof of publication (PDF)
-
Filing of accounts 4 Oct 2024
- Court :
- Greffe du Tribunal de Commerce de toulouse
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 29/02/2024
BODACC C n 20240193, annonce n 1312 · Proof of publication (PDF)
-
Amendment 2 May 2024
- Court :
- Greffe du Tribunal de Commerce de Toulouse
- Amendment :
- Modification de l'administration.
BODACC B n 20240086, annonce n 1281 · Proof of publication (PDF)
-
Amendment 25 Jan 2024
- Court :
- Greffe du Tribunal de Commerce de Toulouse
- Amendment :
- Modification de l'activité.
BODACC B n 20240017, annonce n 851 · Proof of publication (PDF)
-
Filing of accounts 12 Oct 2023
- Court :
- Greffe du Tribunal de Commerce de toulouse
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230197, annonce n 3955 · Proof of publication (PDF)
-
Filing of accounts 22 Dec 2022
- Court :
- Greffe du Tribunal de Commerce de toulouse
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220248, annonce n 4387 · Proof of publication (PDF)
-
Filing of accounts 11 Feb 2022
- Court :
- Greffe du Tribunal de Commerce de toulouse
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20220030, annonce n 3016 · Proof of publication (PDF)
-
Amendment 24 Oct 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE TOULOUSE
- Amendment :
- Nouveau siège.
BODACC B n 20210208, annonce n 449 · Proof of publication (PDF)
-
Filing of accounts 15 Nov 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE TOULOUSE
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2019
BODACC C n 20200222, annonce n 2411 · Proof of publication (PDF)
-
Amendment 12 Dec 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE TOULOUSE
- Amendment :
- Modification de l'activité.
BODACC B n 20190239, annonce n 464 · Proof of publication (PDF)
-
Amendment 17 Mar 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE TOULOUSE
- Amendment :
- Mise en activité de la société.
BODACC B n 20190054, annonce n 434 · Proof of publication (PDF)
Filings and accounts
- Formality 26 Nov 2025
- Formality 11 Jun 2025
- Formality 7 May 2025
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address (empty) → 14 impasse René Couzinet 31500 Toulouse 1 Oct 2026
- capital (empty) → 70000.00 1 Oct 2026
Frequently asked questions about MAXIPHARMA
- What is the SIREN number of MAXIPHARMA?
- The SIREN number of MAXIPHARMA is 843749508. Its intra-community VAT number is FR71843749508.
- Where is the head office of MAXIPHARMA?
- Head office address: 14 IMPASSE RENE COUZINET, 31500 TOULOUSE.
- When was MAXIPHARMA founded?
- MAXIPHARMA was founded on 23 Oct 2018.
- What does MAXIPHARMA do?
- Its declared main activity is: Agents specialised in the sale of other particular products (NAF code 46.18Z).
- What is the revenue of MAXIPHARMA?
- The latest published revenue is 0 €, for the 2025 financial year.
- How many employees does MAXIPHARMA have?
- The declared headcount is 20 to 49 employees. Insee data for 2023.
- Is MAXIPHARMA subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.